Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
STAT3d
After a rocky debut for new RSV tools, hopes are high as a new season approaches
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
Researchers investigate potential link between RSV and sudden unexpected infant deaths
A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of RSV in 2021, according to a ...
Exclusive: Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...
The American Journal of Managed Care2d
Adult RSV Hospitalizations: Clinical Characteristics, Risk Factors for Severe Outcomes
A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...
Everything You Need to Know About Getting the RSV Vaccine During Pregnancy
If you, for some reason, don’t get the RSV vaccine while you’re pregnant, you can (and should!) still protect your baby after ...
High-resolution images of RSV may expose stubborn virus's weak points
The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...